Current place of progestins in the treatment of endometriosis-related complaints

REFERENCES

• Hammond CB, Haney AF. Conservative treat-ment of endometriosis. Fertil Steril 1978;30: 497–509
   PubMed Web of Science ®Google Scholar
• Kauppila A, Rönnberg L, Viehko R. Steroidrezeptoren in endometrischem Gewebe. Endometriose 1986;4:56–9
   Google Scholar
• Vierikko P, Kauppila A, Rönnberg L, Viehko R. Steroidal regulation of endometriosis tissue. Fertil Steril 1985;43:218–23
   PubMed Web of Science ®Google Scholar
• Obolensky W, Kamber J. Therapie der endometriose mit Dydrogesteron in Depot form. Ther Umsch 1973;30:558–62
   PubMedGoogle Scholar
• Schweppe K-W. Klinik und Morphologie der Endometriose. Stuttgart, New York: Schattauer, 1984
   Google Scholar
• Telimaa S, Puolakka J, Rönnberg I, Kauppila A. Placebo controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol1987;1:13–19
   Google Scholar
• Schweppe K-W. Einsatz der Gestagene zur Behandlung der Endometriose — Medrogeston versus Danazol. In Schindler AE, Ebert Ch, eds. Menopause Aktuell. Basel: Aesopus, 1996:85–93
   Google Scholar
• Korte W, Beck KJ, Scherholz KP. Operative Behandlung der Endometriose und Lagzeittherapie mit Lynestrenol. Geburtsh Frauenheilk 1970;30: 122–32
   PubMedGoogle Scholar
• Andrews MC, Andrews WC, Strauss AF. Effects of pro gestin induced pseudopregnancy on endo-metriosis: clinical and microscopic studies. Am J Obstet Gynecol 1959;78: 776
   Google Scholar
• Johnston WIH. Dydrogesterone and endo-metriosis. Br J Obstet Gynaecol 1976;83:77
   PubMedGoogle Scholar
• Moghissi KS, Boyce CR. Management of endo-metriosis with oral medroxyprogesterone acetate. Obstet Gynecol 1976;47:265
   PubMed Web of Science ®Google Scholar
• Willemsen WNP, Rolland R, Vemer HM, Thomas CMG. Low versus high medroxy-progesterone acetate in the treatment of endometriosis. Arch Gynecol 1985;237(Suppl): abstr 12.79.02
   Google Scholar
• Donnez J, Nisolle-Pochet M, Lemaire-Rubbers M, Casanas-Roux F, Kaufmann Y. Combined (hormonal and microsurgical) therapy in infertile women with endometriosis. Fertil Steril 1987;48: 239–42
   PubMed Web of Science ®Google Scholar
• Köhler G, Göretzlhner G. Endometriosetherapie mit Dienogest. Zbl Gynäkol 1987;109:795
   PubMedGoogle Scholar
• Kaiser E, Wagner ThA. Die Behandlung der Endometriose mit Dydrogesteron. TW Gynäkol 1989;2:386
   Google Scholar
• Timmonen S, Johansson CJ. Endometriosis treated with lynestrenol. Ann Chir Gynaecol 1968;57:144
   Google Scholar
• Chalmers JA. Pseudo-pregnancy treatment of endometriosis. In Proceedings of International Symposium of OBstetrics and Gynecology. Milan: Fandezino Carlo Erba, 1969:66
   Google Scholar
• Seliger E, Kaltwasser P, Schneider F, Rothe K, Röpke F. Behandlung der Endometriose mit Dienogest — EinfluB auf den Rezeptorstatus im Endometrium und vergleichende Bindungs-studien. In Teichmann AT, ed. Dienogest — Präklinik und Klinik eines Gestagens. Berlin, New York: W. de Gruyter Verlag, 1995:231
   Google Scholar
• Malkonen M, Manninen V, Hirvonen E. Effects of danazol and lynestrenol on serum lipoproteins in endometriosis. Clin Pharmacol Ther 1980;28:602
   PubMed Web of Science ®Google Scholar
• Teichmann AT, Wieland H, Cremer P, Kuhn W, Seidel D. Lipoproteinveränderungen unter Lynestrenol und Danazol in der hormonellen Behandlung der Endometriose. Geburtsh Frauenheilk 1984;44:171
   PubMed Web of Science ®Google Scholar
• Huovinen K, Tikkanen MH, Autio S, et al. Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate. Acta Obstet Gynecol Scand 1991;70:349
   PubMed Web of Science ®Google Scholar
• Cullberg C. Androgenic, anabolic, estrogenic and antiestrogenic effects of desogestrel and lynestrenol: effects on serum proteins and vaginal cytology. Contraception 1984;30:73
   PubMed Web of Science ®Google Scholar
• Köhler G. Die Therapie der Endometriose mit Dienogest: eine Renaissance der Gestagene. In Teichmann AT, ed. Dienogest — Präklinik und Klinik eines Gestagens. Berlin: W. de Gruyter Verlag 1995:244
   Google Scholar
• Nevinny-Stickel J. Die Bedeutung des Gestageneffektes auf das Endometrium ftir die Behandlung der Endometriose. Geburtsh Frauenheilk 1962;22:689
   Google Scholar
• Hugentobler R. Die Behandlung der Endo-metriose mit hochdosiertem Primo lut-No r. Thesis, Zürich, 1971
   Google Scholar
• Richter K, Schmidt-Tannwald I, Terruhn V. Endometriosis externa. 459 histologisch veri-fizierte Beobachtungen. Gynäkol Praxis 1981;5: 97
   Google Scholar
• Schindler AE. Prognose der Endometriose nach Therapie. Endometriose 1984;3;8
   Google Scholar
• Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril 1997;68:393–401
   Google Scholar
• Schlaff WD, DugoffL, Damewoo d MD, Rock JA. Megestrol acetate for treatment of endometriosis. Obstet Gynecol 1990;75:646–8
   PubMed Web of Science ®Google Scholar
• Luciano AA, Turksoy RN, Carleo J. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet Gynecol 1988;72:323–7
   Google Scholar
• Walker SM. The treatment of endometriosis with dydrogesterone. Br J Clin Pract 1982;24(Suppl): 40–6
   Google Scholar
• Roland M, Leisten D, Kane R. Endometrio-sis therapy with medroxyprogesterone acetate. J Reprod Med 1976;17:249–52
   Google Scholar
• Smith L. The treatment of endometriosis by oral progestogens. Proc R Soc Med 1968;61:358–60
   PubMedGoogle Scholar
• Thomassen H, Berthelsen HG. The treatment of endometriosis with progestogens. Dan Med Bull 1966;13:33–5
   PubMed Web of Science ®Google Scholar
• Schweppe K-W. GnRH analogues: state of the art 1996. In Lunenfeld B, Insler V, eds. GnRH Analogues. Carnforth, UK: Parthenon Publishing Group, 1996:83–94
   Google Scholar
• Vercellini P, Trespidi L, Vendola N, et al. A gonadotropin releasing hormone agonist versus a low dose OC for pelvic pain associated with endo-metriosis. Fertil Steril 1993;60:75–9
   PubMed Web of Science ®Google Scholar
• Regidor PA, Regidor M, Schmidt M, et al. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol 2000;14:1–8
   PubMed Web of Science ®Google Scholar